secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001193125-25-260924
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA secures $3M bridge loan at 3% monthly interest, secured by ImmuneFx patents
--------------------------------------------------------------------------------

- Initial $1.5M advance from Matthew Nachtrab Revocable Trust on Oct 27, 2025; up to $3M total available.
- Interest at 3% per month (36% annual); $180K loan fee plus warrants covering 10% of each advance.
- Loan secured by first-priority lien on U.S. patents for ImmuneFx technology platform.
- Maturity Dec 31, 2025 or 30 days after an equity raise >$12M; proceeds for working capital.
- Prepayment allowed without penalty; lender may fund additional $1.5M upon written request.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312525260924/0001193125-25-260924-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312525260924/hura-20251027.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-260924

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer